Reports
Reports
Sale
The global cell expansion market size was valued at USD 21 billion in 2023, driven by the rising incidence of chronic diseases and intensive research activities for cell-based therapies. The market is expected to grow at a CAGR of 16.2% during the forecast period of 2024-2032, with the values likely to reach USD 81 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The cell expansion market is experiencing significant growth and innovation, particularly in the fields of cell therapy, regenerative medicine, and biotechnology. Billions of therapeutic cells are usually needed for a single dose of cell therapy. Thus, cell culture and expansion form a critical step in the manufacturing as well as development of cell therapy, which has the potential to address the unmet medical needs of a growing population base. With cell-based therapies currently undergoing rapid development to treat chronic diseases such as cancer, diabetes, and neurodegenerative diseases, the cell expansion market demand is expected is witness a striking surge.
Key drivers of the market include the rise in geriatric population and the growing prevalence of chronic diseases. In the United States, heart disease is the most common cause of mortality followed by cancer. Further, it is estimated that 41 out of 100 men and 39 out of 100 women will develop cancer in their lifetime. The increased risk of developing cancer prompts the need for effective therapeutics, which is expected to accelerate the market growth of the cell expansion sector. In addition, intensive research activities directed at developing novel cell therapies will boost the market size. These research initiatives are increasingly supported by significant investments from private and public organizations, which will positively impact the market landscape.
The cell expansion market growth is also aided by the rising application of cell expansion protocols in regenerative medicine and stem cell research to counter the growing cancer cases. Technological advancements such as the automation of cell expansion processes will further augment the market share in the forecast period.
Intensive Research in Stem Cell Expansion
Robust research efforts in the field of cell expansion to support high manufacturing capacities have paved the way for rapid advancements. In May 2023, researchers from the University of Tokyo discovered a technique to scale up the number of human blood stem cells in the lab. The research, originally published in Nature, found that artificially boosting the PI3K phosphorylation mechanism can trigger the human blood stem cells or hematopoietic stem cells (HSCs) to expand successfully. The production of a large number of HSCs opens up new possibilities for medical therapies for treating leukemia and other blood disorders as well as for researchers studying blood stem function. This expanded scope of applications drives the need for cell expansion technologies, which may increase the cell expansion market share in the coming years.
Automation of Cell Expansion Protocols to Boost Market Value
Advances in cell expansion techniques and technologies including automation of cell expansion protocols are facilitating efficiency and scalability in cell manufacturing processes. These advancements will reduce production costs while improving the quality and consistency of cell-based products. Such developments are expected to expand the cell expansion market size in the coming years.
In January 2024, Multiply Labs (a United States-based robotics company that serves the pharmaceutical industry), in collaboration with Thermo Fisher Scientific, and Charles River, announced performance results for its proof-of-concept robotic system that aims at automating cell therapy manufacturing processes including cell quantity and quality. The data indicates that the new robotic technology can automate an existing cell expansion process without causing any significant protocol changes or affecting the quality of the final product. The integration of robotics not only minimizes bioprocess and regulatory risks but also speeds up the production of life-saving therapies.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product
Market Breakup by Cell Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
In North America, the cell expansion sector is flourishing due to the rising investments by biotechnology companies to develop effective therapies including cell-based therapies. Another key driver is the increased strategic partnerships among the key market players to speed up the development of their products. In November 2023, a United States-based company 908 Devices Inc. known for its chemical and biochemical analysis products, and Terumo Blood and Cell Technologies (Terumo BCT) announced a collaboration initiative to provide on-line monitoring of Terumo BCT products. This collaboration integrates 908 Devices' MAVEN, an on-line glucose and lactate analyzer, into Terumo BCT's Quantum Flex platform. This advancement aims to accelerate cell and gene therapy development and manufacturing by providing real-time insights and control without manual sampling.
Europe also holds a substantial cell expansion market share, owing to the growing geriatric population and the prevalence of various diseases. Moreover, the dominance of the regional market can be attributed to the presence of leading market players and a well-established healthcare system that is actively supporting technological advancements in the segment.
In February 2024, AstraZeneca, a global biopharmaceutical company, invested USD 300 million in its Maryland Facility to amplify cell therapy research. The investment will boost the cell therapy capabilities of AstraZeneca, with an initial impetus to critical cancer trials and future commercial supply. With a focus on developing T-cell therapies, the company is expected to create over 150 new jobs in the region. This investment will expand its footprint in cell therapy and novel treatments for various medical conditions. Such investment initiatives spur innovation and development in cell expansion technologies and support market growth.
The key features of the cell expansion market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Cell Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cell Expansion Market (2017-2032) Overview
3.1 Global Cell Expansion Market (2017-2032) Historical Value (2017-2023)
3.2 Global Cell Expansion Market (2017-2032) Forecast Value (2024-2032)
4 Global Cell Expansion Market (2017-2032) Landscape
4.1 Global Cell Expansion Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cell Expansion Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Cell Type
4.2.3 Analysis by Application
5 Global Cell Expansion Market (2017-2032) Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cell Expansion Market (2017-2032) Segmentation
6.1 Global Cell Expansion Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Consumables
6.1.3 Media
6.1.4 Reagent
6.1.5 SERA
6.1.6 Disposables
6.1.7 Instruments
6.1.7.1 Cell Expansion Supporting Equipment
6.1.7.2 Bioreactors
6.1.7.3 Automated Cell Expansion Systems
6.2 Global Cell Expansion Market (2017-2032) by Cell Type
6.2.1 Market Overview
6.2.2 Human Cell
6.2.3 Animal Cell
6.3 Global Cell Expansion Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Regenerative Medicine and Stem Cell Research
6.3.3 Cancer Research
6.3.4 Drug Screening and Development
6.3.5 Tissue Engineering
6.3.6 Other Applications
6.4 Global Cell Expansion Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Biotechnology and Biopharmaceutical Companies
6.4.3 Research Institutes
6.4.4 Cell Banks
6.4.5 Other End User
6.5 Global Cell Expansion Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Cell Expansion Market (2017-2032)
7.1 North America Cell Expansion Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Consumables
7.1.3 Media
7.1.4 Reagent
7.1.5 SERA
7.1.6 Disposables
7.1.7 Instruments
7.1.7.1 Cell Expansion Supporting Equipment
7.1.7.2 Bioreactors
7.1.7.3 Automated Cell Expansion Systems.
7.2 North America Cell Expansion Market (2017-2032) by Cell Type
7.2.1 Market Overview
7.2.2 Human Cell
7.2.3 Animal Cell
7.3 North Cell Expansion Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
7.4 Europe Cell Expansion Market (2017-2032) by Product
7.4.1 Market Overview
7.4.2 Consumables
7.4.3 Media
7.4.4 Reagent
7.4.5 SERA
7.4.6 Disposables
7.4.7 Instruments
7.4.7.1 Cell Expansion Supporting Equipment
7.4.7.2 Bioreactors
7.4.7.3 Automated Cell Expansion Systems.
7.5 Europe Cell Expansion Market (2017-2032) by Cell Type
7.5.1 Market Overview
7.5.2 Human Cell
7.5.3 Animal Cell
7.6 Europe Cell Expansion Market (2017-2032) by Country
7.6.1 United Kingdom
7.6.2 Germany
7.6.3 France
7.6.4 Italy
7.6.5 Others
8 Asia Pacific Cell Expansion Market (2017-2032)
8.1 Asia Pacific Cell Expansion Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Consumables
8.1.3 Media
8.1.4 Reagent
8.1.5 SERA
8.1.6 Disposables
8.1.7 Instruments
8.1.7.1 Cell Expansion Supporting Equipment
8.1.7.2 Bioreactors
8.1.7.3 Automated Cell Expansion Systems.
8.2 Asia Pacific Cell Expansion Market (2017-2032) by Cell Type
8.2.1 Market Overview
8.2.2 Human Cell
8.2.3 Animal Cell
8.3 Asia Pacific Cell Expansion Market (2017-2032) by Country
8.3.1 China
8.3.2 Japan
8.3.3 India
8.3.4 Australia
8.3.5 ASEAN
8.3.6 Others
9 Latin America Cell Expansion Market (2017-2032)
9.1 Latin America Cell Expansion Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Consumables
9.1.3 Media
9.1.4 Reagent
9.1.5 SERA
9.1.6 Disposables
9.1.7 Instruments
9.1.7.1 Cell Expansion Supporting Equipment
9.1.7.2 Bioreactors
9.1.7.3 Automated Cell Expansion Systems.
9.2 Latin America Cell Expansion Market (2017-2032) by Cell Type
9.2.1 Market Overview
9.2.2 Human Cell
9.2.3 Animal Cell
9.3 Latin Cell Expansion Market (2017-2032) by Country
9.3.1 Brazil
9.3.2 Argentina
9.3.3 Mexico
9.3.4 Others
10 Middle East and Africa Cell Expansion Market (2017-2032)
10.1 Middle East and Africa Cell Expansion Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Consumables
10.1.3 Media
10.1.4 Reagent
10.1.5 SERA
10.1.6 Disposables
10.1.7 Instruments
10.1.7.1 Cell Expansion Supporting Equipment
10.1.7.2 Bioreactors
10.1.7.3 Automated Cell Expansion Systems.
10.2 Middle East and Africa Cell Expansion Market (2017-2032) by Cell Type
10.2.1 Market Overview
10.2.2 Human Cell
10.2.3 Animal Cell
10.3 Middle East and Africa Cell Expansion Market (2017-2032) by Country
10.3.1 Saudi Arabia
10.3.2 United Arab Emirates
10.3.3 Nigeria
10.3.4 South Africa
10.3.5 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
16 Supplier Landscape
16.1 Thermo Fisher Scientific, Inc.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 GE Healthcare
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Corning Incorporated
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Miltenyi Biotec
16.4.1 Financial Analysis
16.4.2 Financial Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Merck KGaA
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Becton, Dickinson and Company
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 TERUMO BCT, INC.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Takara Bio Inc.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Getinge AB
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Eppendorf AG
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Promocell GmbH
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
17 Global Cell Expansion Market (2017-2032) Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 21 billion in 2023 driven by the rising incidence of chronic diseases and intensive research activities for cell-based therapies across the globe.
The market is anticipated to grow at a CAGR of 16.2% during the forecast period of 2024-2032, likely to reach a market value of USD 81 billion by 2032.
The growing geriatric population, and increased healthcare expenditure to provide innovative and enhanced treatment alternatives are fuelling the demand for the cell expansion industry.
Rising automation of cell expansion processes is a major market trend. In January 2024, Multiply Labs, announced performance results for its proof-of-concept robotic system that aims at automating cell therapy manufacturing processes including cell quantity and quality.
Based on the product, the market is segmented into consumables and instruments. Consumables are further divided into media, reagents, sera, and disposables, while instruments are segmented into cell expansion supporting equipment, bioreactors, and automated cell expansion systems.
Based on the cell type, the market is segmented into human cells and animal cells.
Major end users of the cell expansion sector include biotechnology and biopharmaceutical companies, research institutes, and cell banks, among other end users.
Cell expansion finds its application in regenerative medicine and stem cell research, cancer research, drug screening and development, and tissue engineering, among others.
The major regions of the market include North America, Europe, Asia Pacific, and Latin America, Middle East, and Africa.
Key players involved in the market are Thermo Fisher Scientific, Inc., GE Healthcare, Corning Incorporated, Miltenyi Biotec, Merck KGaA, Becton, Dickinson and Company, TERUMO BCT, INC., TakaraBio Inc., Getinge AB, Eppendorf AG, and Promocell GmbH.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.